Bundac, Claver E. – Trademark Portfolio

Entity Type: 01

Bundac, Claver E. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 2 filings in this category. The portfolio also extends into Class 41 (Education & Entertainment) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include BIOMEDIX ADVOCATES OF FOOD SAFETY. The owner is based in Pomona, CA.

3670 West Temple Avenue

Suite 1960

Pomona, CA 91768

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Bundac, Claver E.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

1
Chemicals (2 filings)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

41
Education & Entertainment (1 filing)

Education; providing of training; entertainment; sporting and cultural activities

Frequently Asked Questions

How many trademarks does Bundac, Claver E. have?

Bundac, Claver E. has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 cancelled.

What trademark classes does Bundac, Claver E. file in?

Bundac, Claver E. files trademarks across 2 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 41 (Education & Entertainment). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.

What are Bundac, Claver E.'s most well-known trademarks?

Bundac, Claver E.'s registered trademark portfolio includes well-known marks such as BIOMEDIX ADVOCATES OF FOOD SAFETY. These are among 1 currently registered trademark in the portfolio.

What is Bundac, Claver E.'s trademark registration success rate?

Bundac, Claver E. has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.